A Phase 2b Randomized, Double-Blind, Vehicle-Controlled, Repeat-Dose, Multi- Center, Efficacy and Safety Clinical Trial of Topically Applied OLT1177 Gel in Subjects With Moderate to Severe Pain Associated With Osteoarthritis of the Knee Following Cessation of Pain Therapy
Phase of Trial: Phase II
Latest Information Update: 29 Dec 2017
Price : $35 *
At a glance
- Drugs Dapansutrile (Primary)
- Indications Osteoarthritis
- Focus Therapeutic Use
- Sponsors Olatec Industries
- 27 Aug 2015 Status changed from active, no longer recruiting to completed as per ClinicalTrials.gov record.
- 07 Aug 2015 Status changed from recruiting to active, no longer recruiting as per ClinicalTrials.gov record.
- 05 Mar 2015 Planned End Date changed from 1 Mar 2015 to 1 Aug 2015 according to ClinicalTrials.gov record.